Abeona Therapeutics Inc (NASDAQ:ABEO) Insider Trading Activity – Director Bought 70,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Abeona Therapeutics Inc (NASDAQ:ABEO)

Stefano Buono , Director of Abeona Therapeutics Inc (NASDAQ:ABEO) reportedly Bought 70,000 shares of the company’s stock at an average price of 7.8 for a total transaction amount of $546,000.00 SEC Form

Insider Trading History For Abeona Therapeutics Inc (NASDAQ:ABEO)

  • On 12/24/2014 Steven H Rouhandeh, Director, bought 250,000 with an average share price of $4.00 per share and the total transaction amounting to $1,000,000.00.
  • On 1/26/2015 Mark J Ahn, Director, bought 25,000 with an average share price of $4.00 per share and the total transaction amounting to $100,000.00.
  • On 7/31/2015 Mark J Ahn, Director, bought 18,182 with an average share price of $5.50 per share and the total transaction amounting to $100,001.00.
  • On 9/20/2016 Todd Wider, Director, bought 5,000 with an average share price of $5.48 per share and the total transaction amounting to $27,400.00.
  • On 4/8/2019 Stephen B. Howell, Director, bought 4,000 with an average share price of $7.77 per share and the total transaction amounting to $31,080.00.
  • On 4/11/2019 Stefano Buono, Director, bought 70,000 with an average share price of $7.80 per share and the total transaction amounting to $546,000.00.

    • Analyst Ratings History For Abeona Therapeutics Inc (NASDAQ:ABEO)

    • On 5/26/2017 FBR & Co Reiterated Rating Buy
    • On 11/22/2017 Jefferies Financial Group Reiterated Rating Buy with a price target of $28.00
    • On 1/24/2018 Royal Bank of Canada Reiterated Rating Buy with a price target of $26.00
    • On 5/16/2018 SunTrust Banks Lower Price Target of rating Buy to Positive with a price target of $23.00
    • On 6/5/2018 Seaport Global Securities Initiated Coverage of rating Buy with a price target of $29.00
    • On 6/27/2018 B. Riley Initiated Coverage of rating Buy with a price target of $26.00
    • On 11/5/2018 Maxim Group Reiterated Rating Buy with a price target of $26.00

    Recent Trading Activity for Abeona Therapeutics Inc (NASDAQ:ABEO)
    Shares of Abeona Therapeutics Inc closed the previous trading session at 7.39 −0.25 3.27% with shares trading hands.